{
    "organizations": [],
    "uuid": "d07d8536a5bab63581d2ba8feced199a1abd2c65",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-lupin-launches-generic-namenda-xr/brief-lupin-launches-generic-namenda-xr-capsules-in-u-s-idUSFWN1QB09Z",
    "ord_in_thread": 0,
    "title": "BRIEF-Lupin Launches Generic Namenda Xr Capsules In U.S.‍​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 21 (Reuters) - Lupin Ltd:\n* LAUNCHES GENERIC NAMENDA XR CAPSULES IN THE US‍​ * SAYS DRUG IS INDICATED FOR TREATMENT OF MODERATE TO SEVERE DEMENTIA OF ALZHEIMER'S TYPE‍​ Source text: bit.ly/2oh09C4 Further company coverage:\n ",
    "published": "2018-02-21T17:45:00.000+02:00",
    "crawled": "2018-02-22T18:18:51.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "lupin",
        "ltd",
        "launch",
        "generic",
        "namenda",
        "xr",
        "capsule",
        "say",
        "drug",
        "indicated",
        "treatment",
        "moderate",
        "severe",
        "dementia",
        "alzheimer",
        "source",
        "text",
        "company",
        "coverage"
    ]
}